Odor-sensing Cells: Key Entry Point for SARS COV-2

SARS-CoV-2 latches on to a biological hook and infects the surface of olfactory supporting cell lining of the upper part of the nose, reports a new study.

'Hook' of cells used by COVID-19 to latch onto and infect cells is up to 700 times more prevalent in the olfactory supporting cells, finds a new study. The findings of the study are published in the European Respiratory Journal.

//These supporting cells are necessary for the function/development of odor-sensing cells. The findings, from a preliminary study of cells lining both the nose and trachea, could advance the search for the best target for topical or local antiviral drugs to treat COVID-19 and offers further clues into why people with the virus sometimes lose their sense of smell. "Our research may advance the search for a definitive reason for how and why that happens, and where we might best direct some treatments," says Andrew Lane, M.D., professor of otolaryngology-head and neck surgery, and director of the Division of Rhinology and Skull Base Surgery at the Johns Hopkins University School of Medicine.

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.

‘Loss of the sense of smell is linked to COVID-19, generally in the absence of other nasal symptoms.’

Lane's medical practice focuses on people with nasal and sinus problems, who oftentimes, he says, lose their sense of smell — a condition called anosmia.

Scientists have known that SARS-CoV-2 latches on to a biological hook on the surface of many types of human cells, called an angiotensin-converting enzyme two receptors (ACE2). The receptor reels in essential molecules.

In a bid to explore the ACE2 link to COVID-19 in more detail, Lane, Mengfei Chen, Ph.D., a research associate in Lane's lab at the Johns Hopkins University School of Medicine, and others on his team took a close look at ACE2 levels in nasal tissue specimens from 19 adult men and women with chronic rhinosinusitis (inflammation of nasal tissue) and in tissues from a control group of four people who had nasal surgeries for issues other than sinusitis.

Middle East Respiratory Syndrome (MERS) - Causes Symptoms Treatment Prevention
MERS, a newly discovered respiratory disease, was recently reported in the Arabian region. MERS is caused by a virus similar to that causing common cold and other respiratory illnesses.

The researchers also studied tissue samples of the trachea from seven people who underwent surgery for abnormal narrowing of the trachea. Cells from children were not examined for this study, in part because they tend to have low ACE2 levels in the cells lining the nose, which may contribute to generally less severe illness among children infected with the SARS-CoV-2 virus. None of the study participants had been diagnosed with COVID-19.

The scientists used a high-resolution imaging technique called confocal microscopy to produce very sharp images of cells lining the nasal and tracheal airways. They used fluorescent stains to identify ACE2 receptors.

Tips to Manage Diabetes in Children During the COVID-19 Pandemic
Impacts of COVID-19 infection on diabetic children will depend on the blood glucose level control. If left uncontrolled, diabetes can severely weaken the immune system due to high blood sugar levels, which makes it harder to treat viral infections like COVID-19 and thus complicates the condition.

They found high levels of ACE2 among nasal cells that give structural support called sustentacular cells. These cells are located in an area called the olfactory neuroepithelium, where odor-sensing neurons are found. The researchers say this area of the nose may be particularly vulnerable to infection and might be the only infected site even when there are no symptoms. Because of this, they urge people to wear masks and wear them correctly.

For the study, depending on the biopsy sample, cells in the olfactory neuroepithelium had a 200-fold to 700-fold increase in ACE 2 proteins compared with other samples from the nose and trachea. Because the cells with high levels of ACE2 are associated with odor sensing, the researchers suggest that infection of these cells may be the reason some people with COVID-19 experience loss of smell.

D614G-Dominant Mutated Strain of SARS-CoV-2
D614G is a mutated strain of SARS-CoV-2. It is believed to be 10 times more infectious than the original strain. D614G was recently detected in Malaysia.

Two of seven trachea specimens had low levels of ACE2 receptors, and the amount of those receptors was similar between study participants with and without chronic rhinosinusitis.

Because the cells lining the nose may prove to be a key entry point for SARS-CoV-2, Lane says there may be ways to target those particular cells with topical antiviral drugs or other therapies directly to that area. The researchers plan to advance this research by investigating COVID-19-infected tissue from the noses of humans to confirm if the SARS-CoV-2 virus does indeed target support cells in the nose.

Funding for the study was provided by the National Institutes of Health's National Institute of Allergy and Infectious Diseases and National Institute on Deafness and other Communication Disorders (R01 AI132590, R01 DC016106.

Other scientists who contributed to the research include Wenjuan Shen, Nicholas Rowan, Heather Kulaga, Alexander Hillel, and Murugappan Ramanathan Jr., of Johns Hopkins.

Source-Newswise